#727 — The Industry Wire

August 1, 2025 Brian Casey 0 min read
  1. New T1D treatments could target the brain.
  2. Major healthcare equipment firm on brink of failure.
  3. UnitedHealth Group to replace CFO.
  4. FDA requires labels to clarify opioid risks.
  5. Trump admin to pilot 340B rebate model next year.
  6. Cigna beats investor expectations on Evernorth growth.
  7. >50% of healthcare orgs attacked with ransomware last year.
  8. Trump admin launches health data sharing initiative.
  9. CMS finalizes 2.6% hospital pay bump for FY2026.
  10. Medicaid cuts drive hospitals’ efficiency overhaul.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Breast Imaging June 25, 2026

AI Risk Prediction’s Long-Term Value June 25, 2026

AI-based calculations of breast cancer risk derived from screening mammograms can track cancer risk as it evolves over time.

Longevity Imaging June 22, 2026

Midjourney’s Imaging Spa Concept Raises Eyebrows June 22, 2026

Generative AI company Midjourney unveiled a new business concept that combines whole-body screening with spa treatments.

Artificial Intelligence June 18, 2026

Top 10 AI Vendors by FDA Approvals June 18, 2026

Who are the top 10 radiology AI vendors by number of FDA authorizations? The agency provided some clarity this week